• Nenhum resultado encontrado

J. Pediatr. (Rio J.) vol.84 número4 suppl. en v84n4s0a01

N/A
N/A
Protected

Academic year: 2018

Share "J. Pediatr. (Rio J.) vol.84 número4 suppl. en v84n4s0a01"

Copied!
1
0
0

Texto

(1)

0021-7557/08/84-04-Suppl/S1

Copyright © 2008 by Sociedade Brasileira de Pediatria

E

DITORIAL

Genetics: an essential tool for the pediatrician

of the 21st century

The impact of genetics on medicine, which had not been

clearly understood when Watson and Crick described the DNA

structure in 1953, became increasingly more evident through-out the following 50 years due to several landmarks that have

been established in this field: mainly the discovery of the genetic code, the creation of techniques that allow for the

manipulation of genetic material and the decoding of the human genome sequence, which was completed in 2003.

A significant amount of information has been

progres-sively made available, and the great majority of medical

jour-nals have been filled with articles approaching the genetic aspects of diseases and/or using genetic tools to understand,

diagnose or treat these diseases, with direct impact on the clinical physician's activity.

Understanding this new information became a necessity

not only for geneticists but also for the general pediatrician, since it is time for this “genetic revolution” to have an impact

on the diagnosis process being implemented, the therapeutic

measures being taken and the counseling being provided to the patient’s family.

Another aspect that is closely related to the impact of the

development of genetics on the medical practice, and mainly

on the pediatrician's practice, is the relevance of the informa-tion obtained from a patient for the whole family, which raises

new ethical issues that need to be discussed.

This supplement is not intended to approach the whole set

of over 5,000 genetic diseases currently known, but its objec-tive is to provide pediatricians with some important examples

of the consequences of the new genetic technologies for the

clinical practice, presenting a summarized overview of the recent changes that are affecting the manner in which the

dis-eases are faced due to genetic advances.

We selected topics that are constantly present in the

pediatrician’s clinical practice and authors with broad experi-ence in these topics. The texts have been written not only to

provide pediatricians with updated information on genetic advances but also to provide guidelines on what is already

possible to use in the medical daily routine.

Enjoy!

1. MD, PhD. Associate professor, Faculdade de Medicina, Pontifícia Universidade Católica do Rio Grande do Sul (PUCRS), Porto Alegre, RS, Brazil.

2. MD. Assistant professor, Center for Pediatric Sleep Disorders, Department of Developmental Neurology and Psychiatry, Faculty of Medicine, Sapienza Univer-sity, Rome, Italy.

No conflicts of interest declared concerning the publication of this editorial.

Suggested citation:Nunes ML, Giugliani R. Genetics: an essential tool for the pediatrician of the 21st century. J Pediatr (Rio J). 2008;84(4 Suppl):S1. doi:10.2223/JPED.1827

Magda Lahorgue Nunes

1

Roberto Giugliani

2

Referências

Documentos relacionados

This state of hypercoagulability can be caused by the increased exposure of phosphatidylserine on the erythrocyte membrane, by platelet activation, by increased adherence of

Finally, in acute lymphoblastic leukemia, factors such as hyperdiploidy and t 12:21 are associated with good prognosis, whereas carriers of t 4:11 and t 9:22 are considered high

5 In this manner, NK cells can perform immune surveillance both by recognition of reduced or absent expression of HLA molecules on target-cells and in response to imbalances

A significant number of genetic association studies have been describing asthma susceptibility genes, but these data demonstrate the extreme complexity of the disease, and

Objective: Although the classic features of fetal alcohol syndrome have been recognized since 1968, research on alcohol teratogenesis has only recently demonstrated that the brain

In Brazil, the National Neonatal Screening Program was set up in 2001, to screen for phenylketonuria, congenital hypothyroidism, sickle-cell anemia and cystic fibrosis.. Screening for

Birth weight-specific mortality for extremely low birth weight infants vanishes by four days of life: epidemiology and ethics in the neonatal intensive care unit... Ambalavanan N,

health-related quality of life in young adolescents: reliability and validity in the Norwegian version of the Pediatric Quality of Life Inventory 4.0 (PedsQL) generic core